Will People Ever Stop Eating Animals?

Why It Matters

Alternative proteins are critical to reducing livestock‑driven emissions and land use, yet cultural resistance threatens the sector’s climate impact and market growth.

Key Takeaways

• Plant‑based meat sales fell 12% in 2023.
• Only 21% of Americans favor cultivated meat.
• Replacing 50% meat could free 650 M hectares.
• Good Food Institute secured billions in research funding.
• Taste, price, convenience remain biggest consumer barriers.

Pulse Analysis

Bruce Friedrich’s new book, *Meat*, arrives as the alternative‑protein industry stands at a crossroads. The Good Food Institute, which he founded, has helped channel billions of dollars of research capital into plant‑based and cultivated products, and major meat packers such as Cargill and Tyson now hold equity stakes. Yet market data show plant‑based meat volumes slipping 12 % in 2023, and a Good Food Institute survey finds only about one‑fifth of U.S. consumers open to lab‑grown meat. The backlash from figures like Robert F. Kennedy Jr. and the “Make America Healthy Again” movement further complicates growth.

The climate case for alternatives remains compelling. Livestock production generates the bulk of agricultural methane and nitrous‑oxide emissions, and the sector would need an additional 3.3 billion hectares of land to meet projected demand of 370 million metric tons of meat per year. Friedrich argues that swapping just half of current consumption for plant‑based or cultivated equivalents could liberate roughly 650 million hectares, enough to restore large swaths of forest and dramatically cut greenhouse‑gas output. This mirrors the early trajectory of electric vehicles, where sustained policy and investment eventually turned a niche market into a mainstream one.

Despite the upside, three hurdles keep alternatives from mass adoption: taste, price, and convenience. Current products still lag behind conventional meat on flavor fidelity and often carry a premium that deters price‑sensitive shoppers. Regulatory pathways for cultivated meat remain fragmented, slowing shelf‑ready launches. Overcoming these barriers will require continued R&D, economies of scale, and clearer labeling standards that reassure consumers the food is “real” rather than ultra‑processed. If the industry can align product performance with consumer expectations, the next decade could see a decisive shift that reshapes the U.S. protein landscape.